Homeβ€ΊSearchβ€ΊTherapeutic Innovation and Regulatory Science

Therapeutic Innovation and Regulatory Science

SAGE Publications Inc. Β· United Kingdom Β· Est. 1990

ISSN2168-4790eISSN2168-4804
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
157
days submission β†’ published
measured Β· last 19 articles Β· accept 142d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.902
H-Indexi
48
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.129
Total Worksi
1,793
Total Citationsi
15,250
2yr Mean Citednessi
1.52
Open Impact Factor alternative

Aims & Scope

Therapeutic Innovation & Regulatory Science is a peer-reviewed journal that focuses on medical product discovery, development, regulation, access, and policy. Official scientific journal of the Drug Information Association (DIA). Provides a platform for researchers, regulators, developers, patient advocacy groups, payers, and other healthcare decision-makers to advance human health. Covers diverse areas from biostatistics and clinical trials to patient-centered product development. Emphasizes on diversity and inclusion from early clinical development to access. Publishes peer-reviewed original research, review articles, commentaries, and letters to the editor on medical product discovery, development, regulation, access, and policy.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1990
FrequencyBimonthly
StatusActive (last: 2026)
Total Publications1,793
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Reviewpeer-reviewed
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

7/12 Β· 58%
βœ…
Do you know the journal / publisher?
SAGE Publications Inc.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2168-4790 / 2168-4804
βœ…
Indexed in a trusted database?
WoS, Scopus
βœ…
Peer review process documented?
peer-reviewed
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
122
939
2019
223
2.3k
2020
109
1.4k
2021
134
1.5k
2022
111
805
2023
132
465
2024
169
247
2025
102
6
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
Public Health, Environmental and Occupational HealthQ1
Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Medical InformaticsPharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Public Health, Environmental and Occupational HealthPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifeStatistical Methods in Clinical TrialsPharmaceutical Economics and PolicyBiomedical Ethics and RegulationEthics in Clinical ResearchPharmaceutical studies and practicesPharmaceutical industry and healthcarePharmacovigilance and Adverse Drug ReactionsBiosimilars and Bioanalytical MethodsMeta-analysis and systematic reviews

Frequently asked questions about Therapeutic Innovation and Regulatory Science

Is Therapeutic Innovation and Regulatory Science a predatory journal?

PubScope has no integrity flags on record for Therapeutic Innovation and Regulatory Science: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Innovation and Regulatory Science?

Therapeutic Innovation and Regulatory Science is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.52.

Is Therapeutic Innovation and Regulatory Science indexed in Scopus and Web of Science?

Therapeutic Innovation and Regulatory Science is indexed in Web of Science, Scopus.

What is the aims and scope of Therapeutic Innovation and Regulatory Science?

Therapeutic Innovation & Regulatory Science is a peer-reviewed journal that focuses on medical product discovery, development, regulation, access, and policy. Official scientific journal of the Drug Information Association (DIA). Provides a platform for researchers, regulators, developers, patient advocacy groups, payers, and other healthcare decision-makers to advance human health. Covers diverse areas from biostatistics and clinical trials to patient-centered product development. Emphasizes on diversity and inclusion from early clinical development to access. Publishes peer-reviewed original

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref